Psychical comorbidity and post-stationary treatmentadherence in patients after allogeneic stem cell transplantatio
- Conditions
- Stem cell Transplantation
- Registration Number
- DRKS00011762
- Lead Sponsor
- Klinik für Psychosomatik und Psychotherapie der Uniklinik Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 61
Inclusion Criteria
Ambulant or stationary patients of the clinic for internal medicine I, for whom a allogenic stem cell transplantation is plannend; age: 18 - 75 years old; signed informed consent
Exclusion Criteria
no informed consent,
<18 years,
> 75 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The treating oncologist performs Prior to the Transplantation and after 3. 12 and 36 months a assessment of the compliance through a 5-point Likert-scale. It shall be examined, if a assessment of adherence prior to the transplantation is possible. For this the Transplant Evaluation Rating Scale (TERS) shall be used to examine if a valide statement about the adherence after the transplantation can be formed. This would have positive effects on the prognosis of patients, but also it could help to avoid cost-intensive stationary residence of transplantation patients. Furthermore, a psychosomatic or psychooncological consulting or therapy would be possible prior to transplantation.
- Secondary Outcome Measures
Name Time Method Through 5 questionnaires shall further Parameters be examined, which could be related to the measured adherence (prior to the Transplantation and after 3, 12 and 36 months): <br>*MESI: handling with medicamentation, especially with immunosuppressives<br>*HADS-D: anxiety and Depression<br>*PHQ-D: Patient health qustionnaire<br>*SF-36: health status qustionnaire<br>* F-SozU: social support